Trial intelligence / Profile preview

Immunogenicity and Safety of Meningococcal ACYW135 Conjugate Vaccine in Children 3-35 Months

NCT05229536Phase 2Completed

Sponsor
Zhifei Green Bamboo
Start
Dec 2018
Primary completion
Nov 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of meningococcal ACYW135 polysaccharide conjugate vaccine in meningococcal meningitis, sponsored by Zhifei Green Bamboo. Started Dec 2018; status: completed.

02

Drugs

meningococcal ACYW135 polysaccharide conjugate vaccine
03

Conditions

meningococcal meningitis

Beyond the preview

Go deeper on NCT05229536.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05229536.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call